Resveratrol suppresses SREBP-1c mRNA and upregulates PPAR-α, thereby diminishing lipid accumulation and hepatocellular pathology in fatty liver disease (Mo et al., 2018). This evidence concerns the gene PPARA and fatty liver disease.